Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Contract Medical International (CMI) is a leading contract development and manufacturing organization (CDMO) specializing in minimally invasive medical devices. The company provides comprehensive services ranging from initial design and prototyping to regulatory approval and high-volume manufacturing of catheters, delivery systems, and implants. CMI focuses on high-growth therapeutic areas such as interventional cardiology, neuroradiology, and peripheral vascular surgery. In 2020, the company was acquired by the Heraeus Group and integrated into its Heraeus Medevio business unit to expand its global medical device manufacturing footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Contract Medical International.